Eli Lilly Corp. buy Guggenheim
Start price
08.10.25
/
50%
€728.50
Target price
08.10.26
€815.37
Performance (%)
21.81%
Price
17.12.25
€887.40
Summary
This prediction is currently active. The BUY prediction by Guggenheim currently has a performance of 21.81%. This prediction currently runs until 08.10.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Eli Lilly Corp. | 4.486% | 4.486% |
| iShares Core DAX® | -1.212% | 1.925% |
| iShares Nasdaq 100 | -4.714% | -1.810% |
| iShares Nikkei 225® | -2.976% | -2.660% |
| iShares S&P 500 | -2.744% | -0.448% |
Comments by Guggenheim for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE:LLY) had its price target raised by analysts at Guggenheim from $875.00 to $948.00. They now have a "buy" rating on the stock.
Ratings data for LLY provided by MarketBeat
Stopped prediction by Guggenheim for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€710.00
16.10.25
16.10.25
€812.06
16.10.26
16.10.26
24.99%
17.12.25
17.12.25
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€556.70
13.08.25
13.08.25
€749.35
13.08.26
13.08.26
59.40%
17.12.25
17.12.25
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€672.80
11.07.25
11.07.25
€806.82
11.07.26
11.07.26
31.90%
17.12.25
17.12.25
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€662.90
20.06.25
20.06.25
€813.01
20.06.26
20.06.26
33.87%
17.12.25
17.12.25
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€656.40
14.04.25
14.04.25
€814.97
14.04.26
14.04.26
35.19%
17.12.25
17.12.25
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€844.20
16.08.24
16.08.24
€935.65
16.08.25
16.08.25
-28.93%
17.08.25
17.08.25
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€706.60
05.08.24
05.08.24
€806.83
05.08.25
05.08.25
-6.30%
06.08.25
06.08.25